NON-ALCOHOLIC FATTY LIVER DISEASE
Clinical trials for NON-ALCOHOLIC FATTY LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new NON-ALCOHOLIC FATTY LIVER DISEASE trials appear
Sign up with your email to follow new studies for NON-ALCOHOLIC FATTY LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug for cholesterol and fatty liver fails to advance
Disease control TerminatedThis early-stage trial tested a new drug called LY3885125 in people with high cholesterol (dyslipidemia) and non-alcoholic fatty liver disease (NAFLD). The main goal was to check safety and how the body processes the drug. The study was terminated, meaning it stopped early, so it…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Sugar-Free diet may shield hispanic kids from fatty liver
Prevention TerminatedThis study tested whether a low-sugar diet could prevent non-alcoholic fatty liver disease (NAFLD) in Hispanic children ages 6 to 9 who were at higher risk. Over two years, researchers compared kids who followed the diet with those who ate normally. The goal was to see if cutting…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: NA • Sponsor: Emory University • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC